MODS accreditation process for regional reference laboratories in Peru: Validation by GenoType® MTBDRplus

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 11, 2010, Pages 1475-1480

  Coronel, J ^a   Roper, M ^a   Mitchell, S ^b   Castillo, E ^c   Gamarra, N ^d   Drobniewski, F ^b   Luna, G ^a   Mendoza, A ^e   Moore, D A J ^a,f,g  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c Dirección Regional de Salud del Callao   (Peru)

^d Laboratorio Regional   (Peru)

^e INSTITUTO NACIONAL DE SALUD   (Peru)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Laboratory accreditation; MODS; MTBDRplus; Tuberculosis

Indexed keywords

ALBUMIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; AZLOCILLIN; CATALASE; GLUCOSE; ISONIAZID; NALIDIXIC ACID; OLEIC ACID; POLYMYXIN B; RIFAMPICIN; TRIMETHOPRIM; TUBERCULOSTATIC AGENT;

ACCREDITATION; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; CLINICAL LABORATORY; DRUG SENSITIVITY; GENOTYPE; LABORATORY TEST; METHODOLOGY; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY; MICROSCOPY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; STANDARD; TUBERCULOSIS; VALIDATION PROCESS;

EID: 78049416685     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Stop TB Partnership Retooling Task Force and New Diagnostic Working Group. New laboratory diagnostic tools for tuberculosis control. Geneva, Switzerland: World Health Organization, 2008. http://apps.who.int/tdr/svc/ publications/non-tdr-publications/diagnostic-tool-tb Accessed August 2010.
2. Stop TB Partnership Retooling Task Force. New technologies for tuberculosis control: a framework for their adoption, introduction and implementation. WHO/HTM/STB/2007.40. Geneva, Switzerland: World Health Organization, 2007.
3. Moore D A, Evans C A, Gilman R H, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355: 1539-1550.
4. Strategic and Technical Advisory Group for Tuberculosis. Report on conclusions and recommendations of 7th meeting of Strategic and Technical Advisory Group for Tuberculosis (STAG-TB). Geneva, Switzerland: World Health Organization, 2007.
5. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640. (Pubitemid 47295497)
6. Sam I C, Drobniewski F, More P, Kemp M, Brown T. Mycobacterium tuberculosis and rifampin resistance, United Kingdom. Emerg Infect Dis 2006; 12: 752-759.
7. Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F. Performance of the GenoType (R) MTBDRplus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin Pathol 2009; 9: 2.
8. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman M E. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 2008; 177: 787-792.
9. Landis J R, Koch G G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
10. Caviedes L, Lee T S, Gilman R H, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000; 38: 1203-1208.
11. Moore D A, Mendoza D, Gilman R H, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42: 4432-4437.
12. Mengatto L, Chiani Y, Imaz M S. Evaluation of rapid alternative methods for drug susceptibility testing in clinical isolates of Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz 2006; 101: 535-542.
13. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 1093-1097.
14. Ejigu G S, Woldeamanuel Y, Shah N S, Gebyehu M, Selassie A, Lemma E. Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis 2008; 12: 332-337.
15. Bwanga F, Hoffner S, Haile M, Joloba M L. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009; 9: 67.
16. Devasia R A, Blackman A, May C, et al. Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance. J Antimicrob Chemother 2009; 63: 1173-1178.
17. Yagui M, Perales M T, Asencios L, et al. Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis 2006; 10: 838-843.